Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prognostic Implications of Multiplex Detection of KRAS Mutations in Cell-Free DNA from Patients with Pancreatic Ductal Adenocarcinoma
Min Kyeong Kim, Sang Myung Woo, Boram Park, et al.
Clinical Chemistry (2018) Vol. 64, Iss. 4, pp. 726-734
Open Access | Times Cited: 85

Showing 1-25 of 85 citing articles:

Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer
Louis Buscail, Barbara Bournet, Pierre Cordelier
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 3, pp. 153-168
Closed Access | Times Cited: 543
Fragment size and level of cell-free DNA provide prognostic information in patients with advanced pancreatic cancer
Morten Lapin, Satu Oltedal, Kjersti Tjensvoll, et al.
Journal of Translational Medicine (2018) Vol. 16, Iss. 1
Open Access | Times Cited: 108
Circulating tumor DNA quantity is related to tumor volume and both predict survival in metastatic pancreatic ductal adenocarcinoma
Marin Strijker, Eline C. Soer, Matteo De Pastena, et al.
International Journal of Cancer (2019) Vol. 146, Iss. 5, pp. 1445-1456
Open Access | Times Cited: 82
Current and Emerging Applications of Droplet Digital PCR in Oncology: An Updated Review
Susana Olmedillas‐López, Rocío Olivera-Salazar, Mariano García‐Arranz, et al.
Molecular Diagnosis & Therapy (2021) Vol. 26, Iss. 1, pp. 61-87
Closed Access | Times Cited: 74
Coupled liquid biopsy and bioinformatics for pancreatic cancer early detection and precision prognostication
Jun Hou, XueTao Li, Keping Xie
Molecular Cancer (2021) Vol. 20, Iss. 1
Open Access | Times Cited: 71
Circulating Tumor DNA: An Emerging Tool in Gastrointestinal Cancers
Olatunji B. Alese, Natalie Cook, Ana Ortega-Franco, et al.
American Society of Clinical Oncology Educational Book (2022), Iss. 42, pp. 279-298
Open Access | Times Cited: 43
Next-generation therapies for pancreatic cancer
Conor Buckley, Eileen M. O’Reilly
Expert Review of Gastroenterology & Hepatology (2024) Vol. 18, Iss. 1-3, pp. 55-72
Open Access | Times Cited: 15
Liquid biopsy in pancreatic ductal adenocarcinoma: current status of circulating tumor cells and circulating tumorDNA
Jee‐Soo Lee, Sung Sup Park, Young Kyung Lee, et al.
Molecular Oncology (2019) Vol. 13, Iss. 8, pp. 1623-1650
Open Access | Times Cited: 74
Enrichment of short mutant cell-free DNA fragments enhanced detection of pancreatic cancer
Xiaoyu Liu, Lingxiao Liu, Yuan Ji, et al.
EBioMedicine (2019) Vol. 41, pp. 345-356
Open Access | Times Cited: 72
Quantitative monitoring of circulating tumor DNA in patients with advanced pancreatic cancer undergoing chemotherapy
Makoto Sugimori, Kazuya Sugimori, Hiromi Tsuchiya, et al.
Cancer Science (2019) Vol. 111, Iss. 1, pp. 266-278
Open Access | Times Cited: 67
Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma
Étienne Buscail, Charlotte Maulat, Fabrice Muscari, et al.
Cancers (2019) Vol. 11, Iss. 6, pp. 852-852
Open Access | Times Cited: 62
Liquid Biopsy in Pancreatic Cancer: Are We Ready to Apply It in the Clinical Practice?
Victoria Heredia-Soto, Nuria Rodrı́guez-Salas, Jaime Feliú
Cancers (2021) Vol. 13, Iss. 8, pp. 1986-1986
Open Access | Times Cited: 51
Recent Discoveries of Diagnostic, Prognostic and Predictive Biomarkers for Pancreatic Cancer
Andrii Khomiak, Marius Brunner, Maximilian Kordes, et al.
Cancers (2020) Vol. 12, Iss. 11, pp. 3234-3234
Open Access | Times Cited: 50
Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
Marisol Huerta, Susana Roselló, Luís Sabater, et al.
Cancers (2021) Vol. 13, Iss. 5, pp. 994-994
Open Access | Times Cited: 47
Clinical Utility of Liquid Biopsy-Based Actionable Mutations Detected via ddPCR
Irina Palacín-Aliana, Noemí Garcia‐Romero, Adriá Asensi-Puig, et al.
Biomedicines (2021) Vol. 9, Iss. 8, pp. 906-906
Open Access | Times Cited: 44
Circulating tumor DNA as a prognostic indicator in resectable pancreatic ductal adenocarcinoma: A systematic review and meta-analysis
Jee-Soo Lee, Tae-Min Rhee, Daniel Pietrasz, et al.
Scientific Reports (2019) Vol. 9, Iss. 1
Open Access | Times Cited: 49
Current Status of Circulating Tumor DNA Liquid Biopsy in Pancreatic Cancer
Miles W. Grunvald, Richard A. Jacobson, Timothy M. Kuzel, et al.
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 20, pp. 7651-7651
Open Access | Times Cited: 49
Molecular profiling of ctDNA in pancreatic cancer: Opportunities and challenges for clinical application
Lavanya Sivapalan, Hemant M. Kocher, Helen Ross‐Adams, et al.
Pancreatology (2020) Vol. 21, Iss. 2, pp. 363-378
Open Access | Times Cited: 49
Prognostic value of circulating cell-free DNA in patients with pancreatic cancer: A systemic review and meta-analysis
Linyan Chen, Yi Zhang, Yuan Cheng, et al.
Gene (2018) Vol. 679, pp. 328-334
Closed Access | Times Cited: 48
A systematic review and meta-analysis of the association between circulating tumor DNA (ctDNA) and prognosis in pancreatic cancer
Deniz Can Güven, Taha Koray Şahin, Hasan Cagri Yildirim, et al.
Critical Reviews in Oncology/Hematology (2021) Vol. 168, pp. 103528-103528
Closed Access | Times Cited: 36
Application of plasma circulating KRAS mutations as a predictive biomarker for targeted treatment of pancreatic cancer
Mi Rim Lee, Sang Myung Woo, Min Kyeong Kim, et al.
Cancer Science (2024) Vol. 115, Iss. 4, pp. 1283-1295
Open Access | Times Cited: 5
Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples
Sun Il Choi, A-Ra Jeon, Min Kyeong Kim, et al.
Frontiers in Oncology (2019) Vol. 9
Open Access | Times Cited: 38
Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials
Daniel Pietrasz, Shufang Renault, Julien Taı̈eb, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 3, pp. 440-448
Open Access | Times Cited: 29
Exosomes as prognostic biomarkers in pancreatic ductal adenocarcinoma—a systematic review and meta-analysis
Ștefania Bunduc, Noémi Gede, Szilárd Váncsa, et al.
Translational research (2022) Vol. 244, pp. 126-136
Open Access | Times Cited: 21
Circulating tumour DNA: a challenging innovation to develop “precision onco-surgery” in pancreatic adenocarcinoma
Daniel Pietrasz, Elisabetta Sereni, Francesco Lancelotti, et al.
British Journal of Cancer (2022) Vol. 126, Iss. 12, pp. 1676-1683
Open Access | Times Cited: 19
Page 1 - Next Page

Scroll to top